Trial Profile
An Effectiveness and Safety Study of Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2019
Price :
$35
*
At a glance
- Drugs Varenicline (Primary) ; Nicotine
- Indications Smoking withdrawal
- Focus Adverse reactions; Therapeutic Use
- 08 Mar 2019 Status changed from recruiting to withdrawn prior to enrolment.
- 11 Jul 2018 New trial record